OCD Treatment Online: Preliminary results of the OCD? Not Me! self-guided iCBT program for young people with OCD
Date Submitted: Nov 22, 2015
Open Peer Review Period: Nov 24, 2015 - Jan 19, 2016
Background: The development and evaluation of e-mental health interventions provides a potential solution for current limitations in the acceptability, availability and accessibility of mental health care for young people with obsessive-compulsive disorder (OCD). This study is the first of its kind to report on the effectiveness of fully-automated online treatment for young people (12-18 years) with OCD. Objective: We aimed to conduct a preliminary evaluation of the effectiveness of the OCD? Not Me! program for reducing OCD-related psychopathology in young people (12-18 years). This program is an eight-stage, fully-automated online cognitive behavioural treatment for OCD. Methods: The current data were taken from a parent study in which an open trial design is being used to evaluate the effectiveness of the OCD? Not Me! program. Participants were required to have at least subclinical levels of OCD to be offered the online program. Participants with moderate-high suicide/self-harm risk, or symptoms of eating disorder or psychosis were not offered the program. OCD symptoms and severity were measured at pre- and post-test, and at the beginning of each stage of the program. Data were analysed with generalized linear mixed models (GLMM). Results: A total of 334 people were screened for inclusion in the study, with 132 participants aged 12-18 years providing data for the final analysis. Participants showed significant reductions in OCD symptoms (P < .001) and severity (P < .001) between pre- and post-test. Conclusions: These preliminary results suggest that fully-automated iCBT holds promise as way of increasing access to treatment for young people with OCD, however further research needs to be conducted to replicate the results and to determine the feasibility of the program. Clinical Trial: The trial was registered on 8 February 2013 with the Australian New Zealand Clinical Trials Registry (ACTRN12613000152729).